Parvovirus Reactivation in COVID-19
HCA Houston Healthcare Kingwood
sars-cov-2, covid-19, hypoproliferative anemia, immunosuppression, parvovirus b-19, parvovirus reactivation
Critical Care | Internal Medicine | Pulmonology | Respiratory Tract Diseases | Virus Diseases
Anemia is a diagnostic challenge in patients with coronavirus disease 2019 (COVID-19). This is due to the broad differential of etiologies for anemia, which includes bleeding, bone marrow suppression secondary to sepsis, and hemolytic anemia. Here, we present a first-ever case of otherwise unexplained anemia in a patient receiving treatment for COVID-19 secondary to parvovirus B19 reactivation. While parvovirus infections often present as acute states of anemia, this patient developed a case of reactivation secondary to immunosuppression from COVID-19 treatment. This case indicates the importance of assessing for parvovirus infections in COVID-19 patients with otherwise unexplained anemia.
Publisher or Conference
Lai PY, Vu A, Sarva ST, Jayaraman G, Kesavan R. Parvovirus Reactivation in COVID-19. Cureus. 2021;13(9):e17796. Published 2021 Sep 7. doi:10.7759/cureus.17796